{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:25:16Z","timestamp":1792009516450,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["101001791"],"award-info":[{"award-number":["101001791"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["454024652"],"award-info":[{"award-number":["454024652"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"European Commission Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["764474"],"award-info":[{"award-number":["764474"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["454024652"],"award-info":[{"award-number":["454024652"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["322900939"],"award-info":[{"award-number":["322900939"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR 219"],"award-info":[{"award-number":["TRR 219"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.kint.2021.10.029","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T20:26:17Z","timestamp":1636575977000},"page":"338-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Altered vitamin K biodistribution and metabolism in experimental and human chronic kidney disease"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8097-7660","authenticated-orcid":false,"given":"Nadine","family":"Kaesler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Schreibing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2491-6393","authenticated-orcid":false,"given":"Thimoteus","family":"Speer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia de la","family":"Puente-Secades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas","family":"Rapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Drechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Kabgani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kuppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9921-4284","authenticated-orcid":false,"given":"Peter","family":"Boor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Schurgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Kramann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Floege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2021.10.029_bib1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2021.10.029_bib2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/00365590410031715","article-title":"Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease","volume":"38","author":"Yao","year":"2004","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.kint.2021.10.029_bib3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12882-019-1367-1","article-title":"Coronary calcification as a predictor of cardiovascular mortality in advanced chronic kidney disease: a prospective long-term follow-up study","volume":"20","author":"Cano-Megias","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2021.10.029_bib4","doi-asserted-by":"crossref","first-page":"F891","DOI":"10.1152\/ajprenal.00163.2014","article-title":"A\u00a0current understanding of vascular calcification in CKD","volume":"307","author":"Paloian","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2021.10.029_bib5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1160\/TH08-02-0087","article-title":"Matrix Gla-protein: the calcification inhibitor in need of vitamin K","volume":"100","author":"Schurgers","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.kint.2021.10.029_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000371449","article-title":"Vitamin K antagonists predispose to calciphylaxis in patients with end-stage renal disease","volume":"129","author":"Galloway","year":"2015","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2021.10.029_bib7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1681\/ASN.2010040339","article-title":"Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD","volume":"22","author":"Schlieper","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.10.029_bib8","first-page":"298","article-title":"Determination of phylloquinone and menaquinones in food: effect of food matrix on circulating vitamin K concentrations","volume":"30","author":"Schurgers","year":"2000","journal-title":"Haemostasis"},{"key":"10.1016\/j.kint.2021.10.029_bib9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ki.2013.530","article-title":"Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation","volume":"86","author":"Kaesler","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.10.029_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0304-4165(02)00147-2","article-title":"Differential lipoprotein transport pathways of K-vitamins in healthy subjects","volume":"1570","author":"Schurgers","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.kint.2021.10.029_bib11","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1681\/ASN.2017070798","article-title":"HDL in CKD-the devil is in the detail","volume":"29","author":"Kronenberg","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.10.029_bib12","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1681\/ASN.2011070668","article-title":"Serum amyloid A in uremic HDL promotes inflammation","volume":"23","author":"Weichhart","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.10.029_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2021.10.029_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41586-020-2941-1","article-title":"Decoding myofibroblast origins in human kidney fibrosis","volume":"589","author":"Kuppe","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.kint.2021.10.029_bib15","first-page":"213","article-title":"Production of a new monoclonal antibody specific to human des-gamma-carboxyprothrombin in the presence of calcium ions: application to the development of a sensitive ELISA-test","volume":"16","author":"Belle","year":"1995","journal-title":"J\u00a0Immunoassay"},{"key":"10.1016\/j.kint.2021.10.029_bib16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.immuni.2013.02.009","article-title":"Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2","volume":"38","author":"Speer","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.kint.2021.10.029_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41590-019-0548-1","article-title":"Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation","volume":"21","author":"Zewinger","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.kint.2021.10.029_bib18","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1161\/01.ATV.0000173313.46222.43","article-title":"Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification","volume":"25","author":"Schurgers","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2021.10.029_bib19","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.kint.2021.10.029_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13059-016-0947-7","article-title":"Pooling across cells to normalize single-cell RNA sequencing data with many zero counts","volume":"17","author":"Lun","year":"2016","journal-title":"Genome Biol"},{"key":"10.1016\/j.kint.2021.10.029_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000451068","article-title":"Vitamin K metabolism in a rat model of chronic kidney disease","volume":"45","author":"McCabe","year":"2017","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2021.10.029_bib22","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.05560","article-title":"The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase","volume":"4","author":"Schumacher","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.kint.2021.10.029_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125737","article-title":"Functional characterization of the vitamin K2 biosynthetic enzyme UBIAD1","volume":"10","author":"Hirota","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2021.10.029_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/eci.12718","article-title":"Does statins promote vascular calcification in chronic kidney disease?","volume":"47","author":"Chen","year":"2017","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.kint.2021.10.029_bib25","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","article-title":"Proton pump inhibitors affect the gut microbiome","volume":"65","author":"Imhann","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.kint.2021.10.029_bib26","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.kint.2021.06.037","article-title":"Vitamin K and cardiovascular complications in chronic kidney disease patients","volume":"100","author":"Kaesler","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.10.029_bib27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.20452\/pamw.3041","article-title":"Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3-5","volume":"125","author":"Kurnatowska","year":"2015","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.kint.2021.10.029_bib28","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s11255-019-02275-2","article-title":"The effect of vitamin K2 supplementation on vascular calcification in haemodialysis patients: a 1-year follow-up randomized trial","volume":"51","author":"Oikonomaki","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.kint.2021.10.029_bib29","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1681\/ASN.2020020225","article-title":"Vitamin K supplementation to improve vascular stiffness in CKD: the K4Kidneys randomized controlled trial","volume":"31","author":"Witham","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.10.029_bib30","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021906","article-title":"Treatment to reduce vascular calcification in hemodialysis patients using vitamin K (Trevasc-HDK): a study protocol for a randomized controlled trial","volume":"99","author":"Haroon","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.kint.2021.10.029_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1475-2891-11-93","article-title":"Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women","volume":"11","author":"Sato","year":"2012","journal-title":"Nutr J"},{"key":"10.1016\/j.kint.2021.10.029_bib32","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1182\/blood-2006-08-040709","article-title":"Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7","volume":"109","author":"Schurgers","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.kint.2021.10.029_bib33","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/eurheartj\/ehx118","article-title":"Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease","volume":"38","author":"Zewinger","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.kint.2021.10.029_bib34","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/ndt\/gft080","article-title":"Uraemic dyslipidaemia revisited: role of\u00a0high-density lipoprotein","volume":"28","author":"Speer","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2021.10.029_bib35","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/ki.2012.191","article-title":"Vitamin K intake and status are low in hemodialysis patients","volume":"82","author":"Cranenburg","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.10.029_bib36","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1681\/ASN.2019060579","article-title":"Multicenter randomized controlled trial of vitamin K antagonist replacement by rivaroxaban with or without vitamin K2 in hemodialysis patients with atrial fibrillation: the Valkyrie study","volume":"31","author":"De Vriese","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.10.029_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40697-015-0053-x","article-title":"Inhibiting the progression of arterial calcification with vitamin K in hemodialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage kidney disease","volume":"2","author":"Holden","year":"2015","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.kint.2021.10.029_bib38","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/ndt\/gft459","article-title":"Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol","volume":"29","author":"Krueger","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2021.10.029_bib39","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1021\/acs.jproteome.5b00213","article-title":"A\u00a0comparison of the mouse and human lipoproteome: suitability of the mouse model for studies of human lipoproteins","volume":"14","author":"Gordon","year":"2015","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.kint.2021.10.029_bib40","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0022-2275(20)37904-9","article-title":"Distribution and characterization of the serum lipoproteins and apoproteins in the mouse, Mus musculus","volume":"24","author":"Camus","year":"1983","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.kint.2021.10.029_bib41","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ki.2012.477","article-title":"Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease","volume":"83","author":"McCabe","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.10.029_bib42","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.3390\/nu7085318","article-title":"High-dose menaquinone-7 supplementation reduces cardiovascular calcification in a murine model of extraosseous calcification","volume":"7","author":"Scheiber","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.kint.2021.10.029_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature09464","article-title":"Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme","volume":"468","author":"Nakagawa","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.kint.2021.10.029_bib44","first-page":"416","article-title":"Atorvastatin decreases renal menaquinone-4 formation in C57BL\/6 male mice","volume":"149","author":"Harshman","year":"2019","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.kint.2021.10.029_bib45","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1365-2125.2012.04295.x","article-title":"The effect of omeprazole and esomeprazole on the maintenance dose of phenprocoumon","volume":"74","author":"Verhoef","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.kint.2021.10.029_bib46","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/bjh.13082","article-title":"Influence of proton pump inhibitors and VKORC1 mutations on CYP2C9-mediated dose requirements of vitamin K antagonist therapy: a pilot study","volume":"167","author":"Brunner-Ziegler","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.kint.2021.10.029_bib47","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ajkd.2011.10.041","article-title":"Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial","volume":"59","author":"Westenfeld","year":"2012","journal-title":"Am J Kidney Dis"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253821010565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253821010565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:55:06Z","timestamp":1777474506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253821010565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0085253821010565"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2021.10.029","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered vitamin K biodistribution and metabolism in experimental and human chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2021.10.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}